GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indiva Ltd (TSXV:NDVA) » Definitions » EBIT

Indiva (TSXV:NDVA) EBIT : C$0.26 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Indiva EBIT?

Indiva's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was C$-0.61 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.26 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Indiva's annualized ROC % for the quarter that ended in Mar. 2024 was -6.44%. Indiva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -11.56%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Indiva's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 1.01%.


Indiva EBIT Historical Data

The historical data trend for Indiva's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indiva EBIT Chart

Indiva Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.96 -13.40 -12.55 -6.61 -0.12

Indiva Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.06 0.27 0.32 0.29 -0.61

Competitive Comparison of Indiva's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Indiva's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indiva's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indiva's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indiva's EV-to-EBIT falls into.



Indiva EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indiva  (TSXV:NDVA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Indiva's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-1.772 * ( 1 - 0% )/( (27.625 + 27.44)/ 2 )
=-1.772/27.5325
=-6.44 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Indiva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.456/( ( (21.369 + max(-5.401, 0)) + (21.136 + max(-6.752, 0)) )/ 2 )
=-2.456/( ( 21.369 + 21.136 )/ 2 )
=-2.456/21.2525
=-11.56 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.823 + 4.847 + 0.398) - (15.239 + 0 + 0.23)
=-5.401

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.071 + 4.851 + 0.622) - (16.015 + 0 + 0.281)
=-6.752

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Indiva's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=0.262/25.938
=1.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indiva EBIT Related Terms

Thank you for viewing the detailed overview of Indiva's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Indiva (TSXV:NDVA) Business Description

Traded in Other Exchanges
Address
333 Preston Street, Suite 710, Ottawa, ON, CAN, K1S 1N4
Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands.
Executives
Tweed Inc. 10% Security Holder

Indiva (TSXV:NDVA) Headlines

No Headlines